OLR1 and stroke disorder: Serum sLOX-1 levels >1539.75 pg/mL distinguished the risk of poor prognosis at 3 months after stroke, with a sensitivity of 83.72% and a specificity of 72.00% (area under curve, 0.813; 95% confidence interval (CI), 0.731–0.879, p < 0.001).